Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

Abstract Objectives Autoantibodies against apolipoprotein A1 (anti‐apoA1 IgGs) and its C‐terminal region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease. Cter apoA1 mimetic peptides were shown to reverse the deleterious anti‐apoA1 IgG effects in vitro. We evaluated t...

Full description

Bibliographic Details
Main Authors: Nicolas Vuilleumier, Panagiotis Antiochos, Pedro Marques‐Vidal, Sabrina Pagano, Julien Virzi, Nathalie Satta, Oliver Hartley, Hubert Gaertner, Karim J Brandt, Fabienne Burger, Fabrizio Montecucco, Gerard Waeber, François Mach, Peter Vollenweider
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Clinical & Translational Immunology
Subjects:
anti‐apoA‐1 IgG
ApoE−/− mice
CoLaus study
C‐terminal A1 peptide
passive immunisation
Online Access:https://doi.org/10.1002/cti2.1220

Internet

https://doi.org/10.1002/cti2.1220

Similar Items